HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Kojima Selected Research

Ophthalmic Solutions (Eye Drops)

1/2023The Effect of High Molecular Weight Hyaluronic Acid and Latanoprost Eyedrops on Tear Functions and Ocular Surface Status in C57/BL6 Mice.
5/2020The Effects of High Molecular Weight Hyaluronic Acid Eye Drop Application in Environmental Dry Eye Stress Model Mice.
1/2020The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 (Sod1) Knockout Mice Treated with Antiglaucoma Eye Medications.
8/2019The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress.
4/2018The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
11/2014Functional visual acuity assessment of severe atopic keratoconjunctivitis.
1/2014The effects of 3% diquafosol sodium application on the tear functions and ocular surface of the Cu,Zn-superoxide dismutase-1 (Sod1)-knockout mice.
10/2011The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis.
9/2008Autologous serum eye drops for the treatment of dry eye diseases.
2/2005The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Kojima Research Topics

Disease

106Neoplasms (Cancer)
02/2024 - 01/2002
52Esophageal Squamous Cell Carcinoma
01/2024 - 01/2011
42Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 12/2007
30Dry Eye Syndromes (Dry Eye Syndrome)
01/2023 - 08/2003
22Stomach Neoplasms (Stomach Cancer)
02/2023 - 12/2003
17Pancreatic Neoplasms (Pancreatic Cancer)
02/2024 - 08/2010
17Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 06/2007
17Inflammation (Inflammations)
10/2023 - 01/2006
17Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 01/2011
13Adenocarcinoma
10/2022 - 01/2009
13Neoplasm Metastasis (Metastasis)
01/2022 - 05/2002
13Infections
02/2021 - 05/2002
12Endometrial Neoplasms (Endometrial Cancer)
01/2024 - 11/2013
11Cataract (Cataracts)
01/2024 - 03/2004
8Disease Progression
01/2024 - 01/2009
7Carcinogenesis
01/2023 - 09/2006
7Allergic Rhinitis
08/2021 - 05/2005
7Carcinoma (Carcinomatosis)
07/2020 - 04/2003
7Respiratory Syncytial Virus Infections
01/2016 - 01/2011
6Keratoconus
01/2024 - 07/2013
6COVID-19
10/2023 - 01/2021
6Retinal Detachment (Retinal Detachments)
05/2023 - 01/2017
5Neutropenia
01/2023 - 12/2019
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 10/2016
5Astigmatism
01/2023 - 01/2008
5Myopia
01/2022 - 04/2008
5Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2012
5Proteinuria
01/2020 - 12/2009
4Adenocarcinoma of Lung
01/2024 - 04/2016
4Glaucoma
01/2023 - 03/2014
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 01/2006
4Hypoxia (Hypoxemia)
01/2022 - 07/2011
4Sepsis (Septicemia)
01/2022 - 10/2010
4Wounds and Injuries (Trauma)
01/2022 - 01/2009
4Retinal Perforations
05/2021 - 09/2010
4Febrile Neutropenia
02/2021 - 08/2011

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
02/2024 - 02/2003
26Fluorouracil (Carac)FDA LinkGeneric
01/2024 - 08/2002
23Tight Junction ProteinsIBA
01/2024 - 07/2003
21Cisplatin (Platino)FDA LinkGeneric
01/2024 - 12/2008
17Biomarkers (Surrogate Marker)IBA
05/2023 - 12/2011
16Claudin-4IBA
01/2019 - 12/2004
15Docetaxel (Taxotere)FDA Link
01/2024 - 11/2010
13CytokinesIBA
01/2022 - 01/2006
11NivolumabIBA
02/2024 - 01/2017
11Claudin-1IBA
11/2016 - 07/2003
10pembrolizumabIBA
04/2024 - 01/2019
10Ophthalmic Solutions (Eye Drops)IBA
01/2023 - 02/2005
10ClaudinsIBA
01/2023 - 08/2006
10OccludinIBA
01/2020 - 12/2004
9Immune Checkpoint InhibitorsIBA
02/2024 - 05/2017
9Messenger RNA (mRNA)IBA
09/2022 - 07/2011
8Monoclonal AntibodiesIBA
10/2023 - 07/2012
8Lipoprotein Receptors (Lipoprotein Receptor)IBA
12/2021 - 05/2016
8MARVEL Domain Containing 2 ProteinIBA
08/2020 - 08/2011
7Small Interfering RNA (siRNA)IBA
02/2024 - 09/2011
7Histone Deacetylase InhibitorsIBA
01/2024 - 10/2007
7HMGB1 Protein (HMG1)IBA
12/2023 - 01/2020
7Irinotecan (Camptosar)FDA LinkGeneric
12/2020 - 12/2008
6regorafenibIBA
02/2024 - 12/2016
6AntigensIBA
01/2023 - 05/2005
6PlatinumIBA
10/2022 - 01/2017
6Fluorescein (Funduscein)FDA LinkGeneric
01/2021 - 11/2018
6diquafosolIBA
07/2020 - 07/2013
6Clostridium enterotoxinIBA
11/2013 - 09/2011
5Histone Deacetylases (Histone Deacetylase)IBA
01/2024 - 01/2017
5Paclitaxel (Taxol)FDA LinkGeneric
01/2024 - 01/2009
5Epidermal Growth Factor (EGF)IBA
01/2024 - 08/2003
5Glucose (Dextrose)FDA LinkGeneric
04/2023 - 02/2016
5CreatinineIBA
01/2023 - 11/2016
5LigandsIBA
01/2023 - 02/2007
5InterferonsIBA
09/2022 - 01/2006
5trifluridine tipiracil drug combinationIBA
01/2022 - 01/2016
5Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2016 - 01/2007
5Telomerase (Telomerase Reverse Transcriptase)IBA
11/2014 - 01/2011
4RNA (Ribonucleic Acid)IBA
02/2024 - 01/2022
4theasinensin AIBA
01/2024 - 01/2021
4Claudin-2IBA
01/2023 - 11/2020
4Retinaldehyde (Retinal)IBA
03/2022 - 05/2007
4Indicators and Reagents (Reagents)IBA
11/2021 - 10/2010
4LipidsIBA
01/2021 - 11/2003
4Bevacizumab (Avastin)FDA Link
01/2021 - 12/2009
4SodiumIBA
07/2020 - 04/2018
4rebamipideIBA
08/2019 - 11/2013

Therapy/Procedure

59Therapeutics
02/2024 - 05/2007
45Drug Therapy (Chemotherapy)
04/2024 - 07/2007
27Chemoradiotherapy
10/2023 - 12/2007
14Neoadjuvant Therapy
01/2024 - 08/2013
12Esophagectomy
12/2022 - 10/2012
10Immunotherapy
02/2024 - 07/2011
10Radiotherapy
12/2023 - 12/2016
6Aftercare (After-Treatment)
01/2021 - 10/2007
6Endoscopes
01/2021 - 10/2012
5Phakic Intraocular Lenses
01/2022 - 04/2012
5Lasers (Laser)
07/2020 - 01/2008
4Intraocular Lenses (Intraocular Lens)
01/2024 - 10/2015
4Laser In Situ Keratomileusis (LASIK)
04/2022 - 04/2008
4Lymph Node Excision (Lymph Node Dissection)
01/2022 - 01/2019
4Induction Chemotherapy
02/2021 - 07/2016
4Photochemotherapy (Photodynamic Therapy)
01/2020 - 09/2012